Crystalline Domains: Domain Size 10-50 nm

Component Specifications

Definition

Crystalline domains refer to the ordered, crystalline regions within microcrystalline cellulose particles that form during controlled hydrolysis and mechanical processing. These domains are responsible for the material's compressibility, flow characteristics, and binding properties in pharmaceutical tablet formulations. The size, distribution, and orientation of these domains directly influence the excipient's performance in drug delivery systems.

Working Principle

Crystalline domains function by providing structural integrity and predictable deformation characteristics under compression. During tablet manufacturing, these domains undergo elastic and plastic deformation, creating interparticulate bonds that maintain tablet integrity while allowing controlled drug release. The crystalline structure provides consistent bulk density and flow properties essential for automated pharmaceutical production.

Materials

Pharmaceutical-grade microcrystalline cellulose (MCC) derived from alpha-cellulose through controlled acid hydrolysis, typically meeting USP/NF, Ph.Eur., and JP specifications. Minimum 99.5% cellulose content with controlled degree of polymerization (DP 150-350).

Technical Parameters

Parameter	Typical range	Notes & selection driver
Domain Size	10-50 nm
Bulk Density	0.25-0.45 g/cm³
Tapped Density	0.35-0.55 g/cm³
Moisture Content	≤5.0%
Crystallinity Index	60-85%
PH (10% Suspension)	5.0-7.5
Particle Size Distribution	D50: 50-150 μm

Ranges are indicative industry figures for RFQ preparation, not a supplier commitment. Confirm every value and standard with the legal manufacturer before ordering.

Standards

ISO 9001, ISO 13485, USP <1061>, Ph.Eur. 2.9.36, FDA 21 CFR Part 211

Parent Products

This component is used in the following industrial products

Pharmaceutical-Grade Microcrystalline Cellulose

Purified, partially depolymerized cellulose excipient for pharmaceutical formulations

View Product Details

Engineering Analysis

Risks & Mitigation

Inconsistent domain structure leading to batch variability
Moisture sensitivity affecting crystalline stability
Contamination risk during processing

FMEA Triads

Trigger: Incomplete hydrolysis during manufacturing
Failure: Reduced crystallinity index and poor compression properties
Mitigation: Implement real-time process analytical technology (PAT) monitoring and strict hydrolysis parameter controls

Trigger: Improper drying conditions
Failure: Moisture-induced domain restructuring and reduced flowability
Mitigation: Use controlled humidity drying chambers with validated drying curves and moisture content verification

Industrial Ecosystem

Compatible With

Typical Suppliers & Equivalents

Compliance & Inspection

Tolerance

±2% crystallinity index variation within batch, ±5% between batches

Test Method

X-ray diffraction (XRD) for crystallinity determination, laser diffraction for particle size, USP <701> for disintegration testing

Procurement Evaluation Criteria

A practical evidence checklist for RFQ preparation and supplier evaluation.

Technical documentation

Request current drawings, revision history, and a signed specification sheet.

Manufacturing capability

Verify equipment lists, process limits, capacity, and representative production evidence.

Inspection readiness

Confirm test methods, calibrated equipment, sampling plans, and traceable reports.

Supplier transparency

Check the legal entity, factory address, ownership, certifications, and direct contacts.

CNFX does not score or rank suppliers. Buyers must verify all claims and documents with the legal manufacturer before ordering.

Manufacturers of Crystalline Domains

Manufacturer profiles associated with Crystalline Domains.

Sourcing Crystalline Domains from China?

Tell us your specification and target quantity — we will match it against manufacturer records and come back with the factories that fit.

Request manufacturers We manufacture this

Manufacturer listings support early research and capability understanding. They are not certification, ranking, or transaction guarantees.

Related Components

Back Pressure Regulator

A back pressure regulator is a precision valve that maintains constant upstream pressure in continuous flow reactor systems by controlling downstream pressure.

Fume Extraction Hood

A fume extraction hood is a critical safety component that captures and removes hazardous chemical vapors, fumes, and particulates generated during automated chemical drum filling and sealing operations.

RTD Temperature Sensor

High-precision platinum-based temperature sensor for industrial chemical heating systems

Safety Enclosure & Ventilation

Safety enclosure and ventilation system for automated chemical storage and retrieval systems, designed to contain hazardous materials and maintain safe air quality.

Frequently Asked Questions

What is the primary function of crystalline domains in pharmaceutical applications?

Crystalline domains provide the structural framework that enables microcrystalline cellulose to function as an effective binder and disintegrant in tablet formulations, ensuring consistent compression behavior and predictable drug release profiles.

How do crystalline domains affect tablet hardness and dissolution?

Optimal crystalline domain structure creates a balance between tablet hardness (through effective bonding during compression) and rapid disintegration (through capillary action and swelling), ensuring both mechanical strength and efficient drug release.

Data Basis

Editorial classification, named public sources where available, and source-reviewed manufacturer records. See the editorial policy.

Preliminary Technical Classification

This page supports structured research, RFQ preparation, and supplier evaluation. It does not replace buyer-led supplier qualification, standards review, or technical approval.

Crystalline Domains